—— 要投稿,上万维,轻松学术交流

严正声明

本站非期刊官网,非中介代理,
不向作者收取任何费用!
举报微信:13140028228 冯老师

态度公正、信息求实、投稿自助、使用免费
Clinical & Experimental Immunology(或:Clinical and Experimental Immunology)《临床与实验免疫学》
月刊 - 英国
  • Clinical & Experimental Immunology(或:Clinical and Experimental Immunology)《临床与实验免疫学》
  • SCIE外文期刊
  • 期发文量9
  • 国人占比29.63%
  • 知网外文库
  • 投稿方式--官网投稿
  • 期刊属性

  • 中科分区:4区
    OA期刊:混合
  • 综述期刊:
    TOP期刊:
  • 期均国文:3
    环比增速:500.00%
  • 期刊信息

  • 研究方向:医学-IMMUNOLOGY免疫学
  • 国际刊号:ISSN 0009-9104;EISSN 1365-2249
  • 期刊语言:英语
    出版地区:英国
  • 投稿网址:https://mc.manuscriptcentral.com/cei
  • 电子邮箱:
  • 期刊官网:https://academic.oup.com/cei
  • 作者指南:
  • 出版商网址:http://www.oxfordjournals.org
  • 出版地址:111 RIVER ST, HOBOKEN, USA, NJ, 07030-5774
  • 期刊简介:Clinical & Experimental Immunology《临床与实验免疫学》(月刊). Clinical & Experimental Immunology (CEI) is an authoritative, international and well-respected journal publishing high-quality and impactful research and review articles in the field of translational immunology. The journal is brought to you by the British Society for Immunology.

  • 万维提示


  • 1、投稿方式:在线投稿。

    2、期刊网址:https://academic.oup.com/cei

    3、投稿网址:https://mc.manuscriptcentral.com/cei

    4、官网邮箱:journals@immunology.org(编辑部)

    5、官网电话:+44 (0) 7392 935249(编辑部)

    6、期刊刊期:月刊,一年出版12期。

    2022117日星期一

                                  

     

    投稿须知【官网信息】

     

    Instructions to Authors

    About the Journal

    Clinical & Experimental Immunology (CEI) is a peer-reviewed journal brought to you by the British Society for Immunology. CEI publishes 12 issues per year in four volumes, in print and in online formats. All articles accepted for publication will appear in both versions.

    Please read these instructions carefully and follow them closely. The Editors may return manuscripts that do not follow these instructions.

    Scope of the Journal

    Clinical & Experimental Immunology is an authoritative international journal publishing high-quality papers in translational and clinical immunology that have the potential to transform our understanding of the immunopathology of human disease and/or change clinical practice. Clinical studies and basic immunology studies that inform clinical practice or understanding of disease mechanisms are also welcomed, as are studies in non-human model systems and reports on the physiological mechanisms of immunity as they relate to human disease.

    Papers are published in the following areas of interest:

    Adaptive immunity

    Allergies and Hypersensitivity

    Autoimmunity

    Clinical and Human Immunology

    Immune Recognition

    Immune Regulation

    Immune System Development

    Immunodeficiency

    Immunogenetics

    Immunotherapy and Vaccines

    Infectious Disease

    Inflammation

    Innate Immunity

    Mucosal Immunology

    Neuroimmunology

    Novel Methodologies

    Transplantation

    Tumour Immunology

    In general, the following studies are not published in CEI, unless they represent major breakthroughs in the field:

    New Reagents

    Research Techniques

    Clinical Case Reports

    CEI also publishes review articles on subjects of topical interest to immunologists and clinicians. While many of the reviews published are commissioned by the editors, CEI welcomes unsolicited reviews.

    Contents

    About the Journal

    Editorial Policies

    Submission

    Third-Party Permissions

    Manuscript Preparation: Format, Structure, and Style

    Licence to Publish and Open Access Options

    Editorial Policies

    Details of Oxford University Press’s editorial policies are available.

    Peer Review

    This journal uses single blind peer review. Full details about the peer review process are available.

    Data Policy

    Availability of Data and Materials

    Where ethically feasible, Clinical & Experimental Immunology strongly encourages authors to make all data and software code on which the conclusions of the paper rely available to readers. Authors are required to include a Data Availability Statement in their article.

    We suggest that data be presented in the main manuscript or additional supporting files, or deposited in a public repository whenever possible. Information on general repositories for all data types, and a list of recommended repositories by subject area, is available here.

    Data Availability Statement

    The inclusion of a Data Availability Statement is a requirement for articles published in Clinical & Experimental Immunology. Data Availability Statements provide a standardised format for readers to understand the availability of data underlying the research results described in the article. The statement may refer to original data generated in the course of the study or to third-party data analysed in the article. The statement should describe and provide means of access, where possible, by linking to the data or providing the required unique identifier.

    The Data Availability Statement should be included in the endmatter of your article under the heading ‘Data availability’.

    More information and example Data Availability Statements can be found here.

    ……

    更多详情:

    https://academic.oup.com/cei/pages/general-instructions






欢迎点评!让信息更透明,使投稿更轻松!
  • 审稿时间:
    是否录用:
  • 见刊周期:
    查重要求:
  • 有无课题:
    有无回复:
  • 我的学历:
    我的职称:
  • 审稿费用:
    版面费用:
  • 稿       费:
    稿件字数:
  • 投稿难度:
  • 该刊可发:
  • 投稿主题:
匿名: 验证码: 点击切换验证码
    评分:0

    验证码: 点击切换验证码